Gentech Pharmaceutical CEO Named to Kalos Therapeutics Board
Kalos Therapeutics is in a massive growth stage in terms of advancing their cancer “Super Drug" as well as substantially adding top tier board members to ensure continued growth and global exposure. Kalos board member and Time Magazine cover story cancer dream team leader, Dr. Daniel Von Hoff, is an example of the elite nature of the Kalos Therapeutics board.
View full press release